Published in Circulation on June 01, 1993
Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation (2012) 4.56
Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart (2006) 1.84
Simple area-based measurement for multidetector computed tomography to predict left ventricular size. Eur Radiol (2010) 1.59
A propensity-matched study of the association of cardiothoracic ratio with morbidity and mortality in chronic heart failure. Am J Cardiol (2008) 1.32
Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J (2007) 1.23
Adaptations in autonomic function during exercise training in heart failure. Heart Fail Rev (2008) 1.13
Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol (2003) 1.12
Diagnostic accuracy of cardiothoracic ratio on admission chest radiography to detect left or right ventricular systolic dysfunction: a retrospective study. J R Soc Med (2015) 1.06
What is treatment success in cardiac resynchronization therapy? Europace (2009) 1.02
Factors associated with poor prognosis among patients admitted with heart failure in a Nigerian tertiary medical centre: a cross-sectional study. BMC Cardiovasc Disord (2008) 1.00
Prevalence and incidence of arrhythmias and sudden death in heart failure. Heart Fail Rev (2002) 0.96
Cardiopulmonary Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope. Open Cardiovasc Med J (2010) 0.95
Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart (2004) 0.94
Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP/dt(max) complementary or redundant? Am J Physiol Heart Circ Physiol (2012) 0.93
Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflugers Arch (2006) 0.90
Cardiac repair with adult bone marrow-derived cells: the clinical evidence. Antioxid Redox Signal (2009) 0.88
Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy. Can J Cardiol (2007) 0.87
Assessment of exercise capacity in African patients with chronic heart failure using six minutes walk test. Int J Gen Med (2010) 0.86
Clinical adoption of prognostic biomarkers: the case for heart failure. Prog Cardiovasc Dis (2012) 0.85
Autonomic dysregulation as a novel underlying cause of mitral valve prolapse: a hypothesis. Med Sci Monit (2011) 0.83
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death? Curr Control Trials Cardiovasc Med (2000) 0.83
Clinical validation of the gated blood pool SPECT QBS processing software in congestive heart failure patients: correlation with MUGA, first-pass RNV and 2D-echocardiography. Int J Cardiovasc Imaging (2005) 0.83
Prognostic value of sympathetic innervation and cardiac asynchrony in dilated cardiomyopathy. Eur J Nucl Med Mol Imaging (2008) 0.82
Personalized Computer Simulation of Diastolic Function in Heart Failure. Genomics Proteomics Bioinformatics (2016) 0.82
Pacing in congestive heart failure. Curr Control Trials Cardiovasc Med (2000) 0.81
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Curr Control Trials Cardiovasc Med (2001) 0.81
Relation of ventricular-vascular coupling to exercise capacity in ischemic cardiomyopathy: a cardiac multi-modality imaging study. Int J Cardiovasc Imaging (2009) 0.80
Novel phase-based noise reduction strategy for quantification of left ventricular function and mass assessment by cardiac CT: comparison with cardiac magnetic resonance. Eur J Radiol (2013) 0.80
Excessive breathlessness in patients with diastolic heart failure. Heart (2006) 0.79
Risk factors for mortality in users of ibopamine. Br J Clin Pharmacol (1998) 0.79
Prognostic value of left atrium remodeling after primary percutaneous coronary intervention in patients with ST elevation acute myocardial infarction. J Korean Med Sci (2012) 0.79
New pacing technologies for heart failure. BMJ (2003) 0.79
Association between the Hemoglobin Level and Cardiothoracic Ratio in Patients on Incident Dialysis. Cardiorenal Med (2014) 0.79
Peak circulatory power as an indicator of clinical status in children after Fontan procedure. Pediatr Cardiol (2010) 0.78
Cardiac Systolic Mechanics in Heart Failure with Preserved Ejection Fraction: New Insights and Controversies. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.78
The challenge of prediction and prevention of sudden cardiac death in congestive heart failure. J Interv Card Electrophysiol (2001) 0.78
Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure. Clin Res Cardiol (2009) 0.78
Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy. Eur J Heart Fail (2010) 0.77
The initial slope of the VCO2/VO2-curve (s1) in cardiopulmonary exercise testing is a strong and independent predictor of outcome in patients with previous myocardial infarction. Clin Res Cardiol (2008) 0.77
Impact of oxygen uptake efficiency slope as a marker of cardiorespiratory reserve on response to cardiac resynchronization therapy. Clin Res Cardiol (2010) 0.77
Analysis of ventricular function by CT. J Cardiovasc Comput Tomogr (2014) 0.76
Reduced oxygen uptake increase to work rate increment (DeltaVO2/DeltaWR) is predictable by VO2 response to constant work rate exercise in patients with chronic heart failure. Eur J Appl Physiol (2003) 0.76
Alterations in the calcium homeostasis of skeletal muscle from postmyocardial infarcted rats. Pflugers Arch (2007) 0.76
The relationship between atrial septal aneurysm and autonomic dysfunction. Exp Clin Cardiol (2013) 0.75
Blood gas analysis of the coronary sinus in patients with heart failure. Biomed Rep (2015) 0.75
Association between cardiothoracic ratio, left ventricular size and systolic function in patients undergoing computed tomography coronary angiography. Exp Ther Med (2014) 0.75
The controversy regarding contrast echocardiography and how it affects patients with the cardiometabolic syndrome. J Cardiometab Syndr (2008) 0.75
Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure. Kardiochir Torakochirurgia Pol (2014) 0.75
Cardiovascular and Mortality Outcomes in the Elderly With Impaired Cardiac and Pulmonary Function: The Cardiovascular Health Study (CHS). J Am Heart Assoc (2015) 0.75
Clinical Classification of Heart Failure Patients Using Cardiac Function during Exercise. Exerc Sport Sci Rev (2015) 0.75
Relationship between aerobic capacity and cardiovascular disease risk factors in Thai men and women with normolipidemia and dyslipidemia. J Phys Ther Sci (2015) 0.75
New concepts regarding events that lead to end-stage heart disease. Cardiovasc Drugs Ther (1995) 0.75
Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy. Biophys Rev (2017) 0.75
Assessment of left ventricular dysfunction by nuclear cardiology. Cardiovasc Drugs Ther (1994) 0.75
Risk stratification after myocardial infarction: role of electrical instability, ischemia, and left ventricular function. Cardiovasc Drugs Ther (1994) 0.75
Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III. Drugs (1994) 0.75
Why are doctors so unhappy? There are probably many causes, some of them deep. BMJ (2001) 22.59
Evidence based medicine. BMJ (1995) 21.24
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
What clinical information do doctors need? BMJ (1996) 16.23
Three-dimensional structure of myosin subfragment-1: a molecular motor. Science (1993) 14.90
Informed consent: the intricacies. BMJ (1997) 13.97
An ethical code for everybody in health care. BMJ (1998) 9.13
All changed, changed utterly. British medicine will be transformed by the Bristol case. BMJ (1998) 9.08
Growing pressure on BMJ's obituaries. BMJ (1995) 8.92
Authorship: time for a paradigm shift? BMJ (1997) 8.90
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
The failings of NICE. BMJ (2000) 8.50
The future of medicine. BMJ (1994) 8.14
A good death. An important aim for health services and for us all. BMJ (2000) 8.03
Using evidence to inform health policy: case study. BMJ (2001) 7.99
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet (1999) 7.72
Time to face up to research misconduct. BMJ (1996) 7.66
Beyond conflict of interest. Transparency is the key. BMJ (1998) 7.63
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med (1984) 6.74
Meeting the information needs of health workers in developing countries. BMJ (1997) 6.31
Medicine's core values. BMJ (1994) 5.93
Revel in electronic and paper media. BMJ (2000) 5.82
The GMC on performance. BMJ (1992) 5.57
Informed consent: edging forwards (and backwards) BMJ (1998) 5.52
PubMed Central: creating an Aladdin's cave of ideas. BMJ (2001) 5.49
Does Britain need an academy of medicine? BMJ (1996) 5.47
Effect of open peer review on quality of reviews and on reviewers' recommendations: a randomised trial. BMJ (1999) 5.45
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Rationing: the search for sunlight. BMJ (1992) 5.26
Publishing information about patients. BMJ (1995) 5.19
The future of healthcare systems. BMJ (1997) 5.14
Prejudice against doctors and students from ethnic minorities. Br Med J (Clin Res Ed) (1987) 5.12
The war on drugs. BMJ (1996) 5.11
Global information flow. BMJ (2000) 5.09
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
What makes a good reviewer and a good review for a general medical journal? JAMA (1998) 5.01
Where is the wisdom...? BMJ (1991) 4.85
Medicine and the marginalised. They deserve the best, not the poorest, care. BMJ (2000) 4.80
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67
X-ray structures of the myosin motor domain of Dictyostelium discoideum complexed with MgADP.BeFx and MgADP.AlF4-. Biochemistry (1995) 4.64
Time to register randomised trials. The case is now unanswerable. BMJ (1999) 4.55
PFI: perfidious financial idiocy. A "free lunch" that could destroy the NHS. BMJ (1999) 4.54
Moving beyond journals: the future arrives with a crash. BMJ (1999) 4.49
Rationing: the debate we have to have. BMJ (1995) 4.47
Time to redefine authorship. BMJ (1996) 4.39
Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37
Animal research: the need for a middle ground. BMJ (2001) 4.34
Conflict of interest and the BMJ. BMJ (1994) 4.34
Prison medicine: beginning again. BMJ (1992) 4.29
Measuring the social impact of research. BMJ (2001) 4.17
The case for structuring the discussion of scientific papers. BMJ (1999) 4.16
Peer review: reform or revolution? BMJ (1997) 4.13
Profile of the GMC: The day of judgment comes closer. BMJ (1989) 4.10
Managing the clinical performance of doctors. A coherent response to an intractable problem. BMJ (1999) 4.08
Effect of blinding and unmasking on the quality of peer review: a randomized trial. JAMA (1998) 4.03
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol (2001) 3.92
Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell (1983) 3.89
Protein kinase activity associated with polyoma virus middle T antigen in vitro. Cell (1979) 3.78
Profile of the GMC. 1978 and all that. BMJ (1989) 3.76
"Taken from this place and hanged by the neck...". BMJ (1991) 3.72
The rights of patients in research. BMJ (1995) 3.68
All doctors are problem doctors. BMJ (1997) 3.67
The BMJ's website scales up. BMJ (1998) 3.67
Publishing research supported by the tobacco industry. BMJ (1996) 3.65
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65
How best to organise acute hospital services? BMJ (2001) 3.63
Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med (1997) 3.61
Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell (1984) 3.61
Netprints: the next phase in the evolution of biomedical publishing. BMJ (1999) 3.60
GMC: approaching the abyss. BMJ (2001) 3.52
The deliberate misdiagnosis of major depression in primary care. Arch Fam Med (1994) 3.46
Pleasing both authors and readers. A combination of short print articles and longer electronic ones may help us do this. BMJ (1999) 3.44
New government, same narrow vision. BMJ (1998) 3.40
Don't treat shackled patients. BMJ (1997) 3.40
The woolwich and erith project. Planning a community health service. Lancet (1966) 3.34
Almost no evidence exists that the internet harms health. BMJ (2001) 3.31
Characterization of different tumor antigens present in cells transformed by simian virus 40. Cell (1979) 3.26
Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr (1990) 3.24
The estimation of two collagens from human dermis by interrupted gel electrophoresis. Biochem Biophys Res Commun (1976) 3.22
Opening up BMJ peer review. BMJ (1999) 3.21
Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 3.19
Doctors, unethical treatments, and turning a blind eye. BMJ (1989) 3.13
Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med (1997) 3.08
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst (1999) 3.07
Reconfiguring acute hospital services. No easy answers, but there are principles we should follow. BMJ (1999) 3.07
Authorship is dying: long live contributorship. BMJ (1997) 3.07
Hamster health care. BMJ (2001) 3.06
Promoting research into peer review. BMJ (1994) 3.05
Rationing health care: moving the debate forward. BMJ (1996) 3.03
Evaluation of active compression-decompression CPR in victims of out-of-hospital cardiac arrest. JAMA (1994) 3.01
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res (2000) 3.01
GMC in the dock again. BMJ (1993) 2.99
Maintaining the integrity of the scientific record. BMJ (2001) 2.98
Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem (1983) 2.97
Altered relation of two collagen types in osteogenesis imperfecta. N Engl J Med (1977) 2.93
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science (1988) 2.93
DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry (2004) 2.91
A randomised comparison of strategies for reducing infective complications of induced abortion. Br J Obstet Gynaecol (1998) 2.86